Methylphenidate Hydrochloride · METHYLPHENIDATE HYDROCHLORIDE 5 mg/1 · Tablet, Chewable · Oral · Lupin Pharmaceuticals,Inc.
NDC 43386-0571-01 · 100 TABLET, CHEWABLE in 1 BOTTLE · ANDA · View full market →
5 companies supply this market — a reasonable cushion if one runs into trouble. The price has fallen 31% in a year, to $2.06 per unit — and generics that get this cheap tend to get abandoned rather than defended.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Matched to CMS's representative package for this drug (NDC 31722-0927-01) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.
Not scored — fragility is computed for NADAC-priced NDCs.
OAI inspection at a producing facility (24 months) · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Camber Pharmaceuticals Inc. | METHYLPHENIDATE HYDROCHLORIDE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Camber Pharmaceuticals Inc. | METHYLPHENIDATE HYDROCHLORIDE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Camber Pharmaceuticals Inc. | METHYLPHENIDATE HYDROCHLORIDE 2.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Lupin Pharmaceuticals,Inc. | METHYLPHENIDATE HYDROCHLORIDE 2.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Lupin Pharmaceuticals,Inc. | METHYLPHENIDATE HYDROCHLORIDE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Lupin Pharmaceuticals,Inc. | METHYLPHENIDATE HYDROCHLORIDE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Rising Pharma Holdings, Inc. | METHYLPHENIDATE HYDROCHLORIDE 2.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Rising Pharma Holdings, Inc. | METHYLPHENIDATE HYDROCHLORIDE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Rising Pharma Holdings, Inc. | METHYLPHENIDATE HYDROCHLORIDE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| XLCare Pharmaceuticals, Inc. | METHYLPHENIDATE HYDROCHLORIDE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| XLCare Pharmaceuticals, Inc. | METHYLPHENIDATE HYDROCHLORIDE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| XLCare Pharmaceuticals, Inc. | METHYLPHENIDATE HYDROCHLORIDE 2.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Bryant Ranch Prepack | METHYLPHENIDATE HYDROCHLORIDE 10 mg/1 | Jul 15, 2026 | Aug 29, 2026 |
| Bryant Ranch Prepack | METHYLPHENIDATE HYDROCHLORIDE 2.5 mg/1 | Jul 15, 2026 | Aug 5, 2026 |
| Bryant Ranch Prepack | METHYLPHENIDATE HYDROCHLORIDE 5 mg/1 | Jul 15, 2026 | Aug 5, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Methylphenidate Hydrochloride — NDC 43386-0571-01," retrieved September 3, 2026, https://drugdashboards.com/drug/43386057101.
Free to cite with attribution — see how the data is put together.